Latest News about Pfizer Inc
Recent news which mentions Pfizer Inc
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
January 08, 2024
From CNBC.com News
From CNBC.com News
Cramer's week ahead: Earnings season kicks off after JPMorgan Healthcare Conference
January 05, 2024
From CNBC.com News
Here are the big health sector themes to watch next year
December 22, 2023
From CNBC.com News
Single-stock ETFs tap into the market’s ‘gambling mindset,’ expert says. What investors need to know
December 20, 2023
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
From CNBC.com News
5 things to know before the stock market opens Monday
December 18, 2023
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
December 17, 2023
From CNBC.com News
Pfizer shares fall as 2024 revenue and profit forecast disappoints
December 13, 2023
From CNBC.com News
Biden administration asserts power to seize drug patents in move to slash high prices
December 07, 2023
From CNBC.com News
Free ChatGPT may incorrectly answer drug questions, study says
December 05, 2023
From CNBC.com News
Cramer on Monday's market action: Some investors are headed for a 'nasty hangover'
December 04, 2023
From CNBC.com News
From CNBC.com News
5 things to know before the stock market opens Friday
December 01, 2023
From CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
December 01, 2023
From CNBC.com News
Cramer's Lightning Round: 'I'm not a buyer' of NIO
November 30, 2023
From CNBC.com News
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
November 30, 2023
From CNBC.com News
Covid vaccine rates in the U.S. are slumping — and it will be a challenge to boost them
November 30, 2023
From CNBC.com News
From CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
November 13, 2023
From CNBC.com News
From CNBC.com News
Moderna posts quarterly loss as company takes $1.3 billion write-down on unused Covid shots
November 02, 2023
From CNBC.com News
'We are really keen to join forces with Seagen': Pfizer CEO on plans to acquire cancer drugmaker
October 31, 2023
Tickers
CEO
From CNBC.com News
From CNBC.com News
5 things to know before the stock market opens Monday
October 30, 2023
From CNBC.com News
CNBC Daily Open: Are things about to get more difficult?
October 30, 2023
From CNBC.com News
CNBC Daily Open: The perfect storm
October 29, 2023
From CNBC.com News
Pfizer's combination Covid, flu vaccine will move to final-stage trial after positive data
October 26, 2023
From CNBC.com News
Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition
October 26, 2023
From CNBC.com News
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.